Search site Search ticker symbol

Are you looking for a stock?

Try one of these

Valeant CEO talks about Afexa bid

Valeant Pharmaceuticals is looking to add another company to its lengthy list of acquisitions after it announced on Tuesday a friendly $76-million bid for Afexa Life Sciences. Chairman and CEO Mike Pearson talks to BNN about Valeant's offer. CTV Two CTV News CTV News Channel BNN - Business News Network CP24